The Copaxone ANDA has been at the FDA for 62 months (since Dec 2007) and has been under active review for 55 months (since Jul 2008). The FDA took 59 months to approve MNTA’s Lovenox ANDA.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”